NVDA
74
5
MMC
55
-2
KR
53
-2
ALLE
48
-7
MAC
53
-5
GOOG
55
-10
FITB
66
-2
MLM
51
-6
KMX
58
6
ALL
48
-3
MAS
64
-4
AIG
56
-6
FIS
63
5
NWL
47
-13
APD
42
-2
KIM
57
-3
HPE
68
-3
EMN
49
-16
KEY
68
-2
CB
48
-2
NVDA
74
5
MMC
55
-2
KR
53
-2
ALLE
48
-7
MAC
53
-5
GOOG
55
-10
FITB
66
-2
MLM
51
-6
KMX
58
6
ALL
48
-3
MAS
64
-4
AIG
56
-6
FIS
63
5
NWL
47
-13
APD
42
-2
KIM
57
-3
HPE
68
-3
EMN
49
-16
KEY
68
-2
CB
48
-2
Financhill
Back

Maze Therapeutics Stock Price Chart

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
17

MAZE
Maze Therapeutics

Last Price:
$9.10
Seasonality Move:
--

7 Day Trial

ALL ACCESS PASS

$ 7

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
  • The current trend is moderately bearish and MAZE is experiencing selling pressure, which indicates risk of future bearish movement.

Maze Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 9.71 Sell
20-day SMA: 9.33 Sell
50-day SMA: 10.01 Sell
200-day SMA: 0 Buy
8-day EMA: 9.62 Sell
20-day EMA: 9.53 Sell
50-day EMA: 6.31 Buy
200-day EMA: 2.28 Buy

Maze Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 46.17 Sell
Chaikin Money Flow: -56435 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.13 - 9.99) Sell
Bollinger Bands (100): ( - ) Buy

Maze Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Maze Therapeutics Stock

Is Maze Therapeutics Stock a Buy?

  • Maze Therapeutics share price is 9.06 while MAZE 8-day simple moving average is 9.71, which is a Sell signal.
  • The stock price of MAZE is 9.06 while Maze Therapeutics 20-day SMA is 9.33, which makes it a Sell.
  • Maze Therapeutics 50-day simple moving average is 10.01 while MAZE share price is 9.06, making it a Sell technically.
  • MAZE stock price is 9.06 and Maze Therapeutics 200-day simple moving average is 0.00, creating a Buy signal.

MAZE Technical Analysis vs Fundamental Analysis

Sell
17
Maze Therapeutics (MAZE) is a Sell

Is Maze Therapeutics a Buy or a Sell?

  • Maze Therapeutics stock is rated a Sell
    The current Maze Therapeutics [MAZE] share price is $9.06. The Score for MAZE is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.

Maze Therapeutics Stock Info

Market Cap:
388M
Price in USD:
9.06
Share Volume:
105.7K

Maze Therapeutics 52-Week Range

52-Week High:
17.00
52-Week Low:
6.71
Sell
17
Maze Therapeutics (MAZE) is a Sell

Maze Therapeutics Share Price Forecast

Is Maze Therapeutics Stock a Buy?

  • Maze Therapeutics share price is 9.06 while MAZE 8-day exponential moving average is 9.62, which is a Sell signal.
  • The stock price of MAZE is 9.06 while Maze Therapeutics 20-day EMA is 9.53, which makes it a Sell.
  • Maze Therapeutics 50-day exponential moving average is 6.31 while MAZE share price is 9.06, making it a Buy technically.
  • MAZE stock price is 9.06 and Maze Therapeutics 200-day simple moving average is 2.28, creating a Buy signal.

Fundamental Analysis of Maze Therapeutics

Is Maze Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.07 per share, an increase this year of $17.50 per share, and an increase next year of $0.24 per share.

Technical Analysis of Maze Therapeutics

Should I short Maze Therapeutics stock?

* Maze Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.